Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion type Assertion NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_head.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion description "[The genes E-cadherin (ECAD), transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains 2 (TMEFF2), retinoic acid receptor beta (RAR?), and O-6 methylguanine DNA methyltransferase (MGMT) had high sensitivity (>75%) and specificity for the detection of oral cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_provenance.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion evidence source_evidence_literature NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_provenance.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion SIO_000772 22252571 NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_provenance.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion wasDerivedFrom befree-20150227 NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_provenance.
- NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_assertion wasGeneratedBy ECO_0000203 NP844188.RAQ43LY6i-Dq_g8uIHfbfA9c00eeSinR9oXrNam8mN_QQ130_provenance.